June 18, 2024
A new vaccine to prevent invasive pneumococcal disease and pneumococcal pneumonia in adults has been approved by the US Food and Drug Administration. The injectable drug, […]
June 18, 2024
A panel of eight blood biomarkers may be able to identify which patients will go on to develop Parkinson’s disease (PD) up to 7 years before […]
June 18, 2024
Thank you for taking the time to participate in a Patient Listening Session! Patient Listening Sessions help FDA understand what is important to the patient community […]
June 18, 2024
TOPLINE: Smoking, higher body mass index (BMI), and previous exposure to biologics were linked to poorer responses to biologics among patients with psoriasis, in a meta-analysis. […]
June 18, 2024
A history of traumatic brain injury (TBI) is associated with a 33% increased risk for schizophrenia and a 78% increase in bipolar disorder (BD), with the […]
June 18, 2024
HOUSTON — A new analysis highlights the high burden of insomnia across the Americas, with about 17% of adults suffering from this chronic sleep disorder. “Our […]
June 18, 2024
An ancient Chinese remedy for malaria could offer new hope to the 10% of reproductive-age women living with polycystic ovarian syndrome (PCOS), a poorly understood endocrine […]
June 18, 2024
TOPLINE: A probiotic with good rationale from animal and human studies known as L reuteri (Limosilactobacillus reuteri 6475) failed in a placebo-controlled clinical trial to prevent […]
June 18, 2024
TOPLINE: Nearly one-fifth of people in Sweden during 2015-2019 had diabetic retinopathy (DR) at the time of type 2 diabetes (T2D) diagnosis, indicating longstanding hyperglycaemia and […]